BioCentury
ARTICLE | Financial News

Akcea, Ionis tumble on volanesorsen setback

August 28, 2018 6:01 PM UTC

Akcea Therapeutics Inc. (NASDAQ:AKCA) and Ionis Pharmaceuticals Inc. (NASDAQ:IONS) each fell double-digits on Tuesday following a complete response letter from FDA for Waylivra volanesorsen. Akcea slid $8.39 (25%) to $24.73, while Ionis was down $8.53 (16%) to $45.17. The combined moves represent about a $1.9 billion loss in market cap...